Trajectory for the Regulatory Approval of a Combination of Pertuzumab Plus Trastuzumab for Pre-treated HER2-positive Metastatic Colorectal Cancer Using Real-world Data

Yasutoshi Sakamoto, Hideaki Bando, Yoshiaki Nakamura, Hiromi Hasegawa, Takako Kuwaki, Wataru Okamoto, Hiroya Taniguchi, Yoshihiro Aoyagi, Miki Izumi, Hiroshi Uchigata, Naomi Kuramoto, Nozomu Fuse, Takayuki Yoshino, Atsushi Ohtsu